Pulmonary , gastrointestinal and urogenital pharmacology Physcion induces mitochondria-driven apoptosis in colorectal cancer cells via downregulating EMMPRIN
Pulmonary , gastrointestinal and urogenital pharmacology Physcion induces mitochondria-driven apoptosis in colorectal cancer cells via downregulating EMMPRIN
复制标题
DOI:
--
复制
发表时间:
2015
期刊:
影响因子:
--
通讯作者:
Xue-hong Chen;Hui Gao;Yan-tao Han;Junli Ye;Jing Xie;Chunbo Wang
中科院分区:
文献类型:
--
作者:
Xue-hong Chen;Hui Gao;Yan-tao Han;Junli Ye;Jing Xie;Chunbo Wang
Physcion, an anthraquinone derivative widely isolated and characterized from both terrestrial and marine sources, has anti-tumor effects on a variety of carcinoma cells, mainly through inhibition of cell proliferation, apoptosis induction and cell cycle arrest. However, little is known about the mechanisms underlying its role in tumor progression. In the present study, we investigated the molecular mechanisms involved in physcion-induced apoptosis in human colorectal cancer (CRC) lines HCT116. Our results showed that physcion inhibited tumor cell viability in a doseand time-dependent manner, and induced cell apoptosis via intrinsic mitochondrial pathway. Our results also revealed that physcion treatment significantly inhibited extracelluar matrix metalloproteinase inducer (EMMPRIN) expression in HCT116 cells in a dose-dependent manner and overexpression of EMMPRIN protein markedly reduced physcioninduced cell apoptosis. Furthermore, our results strongly indicated the modulating effect of physcion on EMMPRIN is correlated with AMP-activated protein kinase (AMPK)/Hypoxia-inducible factor 1α (HIF-1α) signaling pathway. Our data provide the first experimental evidence that physcion induces mitochondrial apoptosis in CRC cells by downregulating of EMMPRIN via AMPK/HIF-1α signaling pathway and suggest a new mechanism to explain its anti-tumor effects. & 2015 Published by Elsevier B.V.